WTA Mandates SRY Gene Test for Eligibility
Key Questions
What new eligibility policy has the WTA announced?
The WTA has mandated a one-time SRY gene test for all players to determine eligibility for the women's tour, effective immediately. The test can be done via cheek swab, blood, or saliva sample and aligns the WTA with World Athletics and IOC standards.
How will the SRY gene test be administered?
Players will undergo a one-time test using a cheek swab, blood, or saliva sample. Refusal to take the test will result in disciplinary action.
Are there any transgender players currently on the WTA tour?
The WTA has stated there are no known transgender players currently competing on the tour. The policy applies to all players regardless.
What is Martina Navratilova's position on the new policy?
Navratilova clarified she played no role in creating the policy but expressed support for the WTA's decision. She praised the move as a step toward protecting fair competition.
How does Billie Jean King view the WTA's gene testing requirement?
Billie Jean King has publicly opposed the new eligibility policy. Her stance contrasts with Navratilova's supportive comments.
Why is the WTA implementing this change now?
The policy represents a major shift to align with other major sports bodies like World Athletics and the IOC. It aims to enforce consistent eligibility rules for women's professional tennis.
What are the consequences for refusing the test?
Players who refuse the SRY gene test will face disciplinary action from the WTA. The test is required for continued eligibility on the tour.
Is the gene test a recurring requirement or one-time only?
The WTA has specified it as a one-time mandatory test for all players. No additional testing is mentioned under the current policy.
WTA has mandated the SRY gene test for eligibility, effective immediately, aligning with World Athletics and IOC. Official announcement: one-time test via cheek swab/blood/saliva, no known trans players currently on tour, disciplinary action for refusal. Martina Navratilova clarifies she played no part but supports the move; Billie Jean King opposes. Sabalenka previously voiced concerns; athletes remain silent publicly. This is a major policy shift in women's tennis governance.